Study Design and Setting
Erasmus, tendinopathy
TENDINOPATHY
The study was designed (ClinicalTrials.gov; NCT02938143) and conducted at the Erasmus Medical Center, Rotterdam, the Netherlands. The study was approved by the ethics committee of the Erasmus MC University Medical Center, and all patients provided written informed consent before participation. Patients were enrolled from January 2017 to July 2019. For this specific study, we adhered to the Strengthening the Reporting of Observational studies in Epidemiology guidelines for reporting cohort studies and to the minimum reporting standards for tendinopathy studies according to the International Consensus (ICON) Statement for Tendinopathy.